Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**5'-Fluoro-5'-Deoxyadenosine** is a synthetic fluorinated nucleoside analog of adenosine, in which the hydroxyl group at the 5' position of the ribose ring is replaced by a fluorine atom. This modification increases its resistance to enzymatic degradation and alters its biochemical properties. It is not an approved pharmaceutical drug but is widely used as a research tool in studies of nucleoside metabolism, enzyme mechanisms, and biosynthesis of organofluorines. In nature, it is produced by certain bacteria (e.g., Streptomyces cattleya) via fluorinase-catalyzed reaction between S‑adenosyl-L-methionine (SAM) and fluoride ion, releasing L-methionine as a byproduct[1][4][9]. The compound has been investigated for potential antiviral and anticancer activities due to its ability to interfere with nucleic acid metabolism[4][5]. Its main mechanism involves acting as an analog or substrate mimic in enzymatic reactions related to nucleotide processing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5'-Fluoro-5'-Deoxyadenosine.